New hope for lung cancer patients with brain spread: triple therapy trial

NCT ID NCT07304739

First seen Jan 07, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study tests a combination of three treatments (a targeted drug, chemotherapy into the spine, and precise radiation) as a first treatment for people with a specific type of lung cancer that has spread to the brain and its lining. About 30 adults with EGFR-mutated lung cancer will receive this therapy to see if it delays brain tumor growth. The goal is to control the disease, not to cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CANGZHOU People's Hospital

    RECRUITING

    Cangzhou, Hebei, 061001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin Huanhu Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300350, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin medical university cancer hospital and institute

    RECRUITING

    Tianjin, Tianjin Municipality, 300060, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.